Biohaven Pharmaceutical Holding Co. Ltd.
(NYSE : BHVN)

( )
BHVN PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson -0.19%160.390.7%$1219.30m
PFEPfizer Inc. -0.01%37.600.9%$1016.11m
MRKMerck & Co., Inc. -0.01%76.660.7%$965.59m
ABBVAbbVie, Inc. -0.01%106.891.9%$827.95m
BMYBristol-Myers Squibb Co. -0.02%64.441.0%$731.63m
LLYEli Lilly & Co. -0.05%185.921.1%$577.25m
AZNAstraZeneca Plc 0.00%50.831.2%$442.51m
GSKGlaxoSmithKline Plc 0.05%37.690.2%$214.10m
RPRXRoyalty Pharma Plc 0.00%41.650.2%$157.73m
NVSNovartis AG 0.28%87.440.2%$153.88m
VTRSViatris, Inc. 0.00%13.280.0%$128.16m
CVACCureVac NV 3.81%108.010.0%$90.79m
RGENRepligen Corp. 0.00%213.576.8%$89.09m
SNYSanofi 0.00%50.690.2%$60.91m
ATNF180 Life Sciences Corp. -0.40%10.000.0%$60.56m

Company Profile

Biohaven Pharmaceutical Holding Co. Ltd. is a clinical-stage biopharmaceutical company, which engages in the research and development of late-stage product candidates targeting neurological diseases, including rare disorders. It focuses on a pipeline of product candidates that represent mechanistic platforms, calcitonin gene-related peptide receptor antagonists, and glutamate modulators. The company was founded in September 2013 and is headquartered in New Haven, CT.